To hear about similar clinical trials, please enter your email below
Trial Title:
Perioperative Management of Colorectal Cancer Patients Infected With COVID-19: a Multicenter Prospective Cohort Study.
NCT ID:
NCT05682898
Condition:
Colorectal Cancer
Surgical Procedure, Unspecified
Conditions: Official terms:
Colorectal Neoplasms
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Procedure
Intervention name:
Timing of colorectal cancer surgery
Description:
The timing of colorectal cancer surgery is different according patients' different
conditions which is difined as more than 7 weeks or less than 7 weeks.
Arm group label:
Less than 7 weeks
Arm group label:
More than 7 weeks
Summary:
This trial is a multicenter prospective cohort study to explore timing of colorectal
cancer surgery after COVID-19 infection so that can assist clinicians and patients.
Currently, there is less evidence on perioperative outcomes after COVID-19 vaccination
and the omicron variant. Therefore, it is necessary to update previously published
consensus which recommends that patients should avoid elective surgery within 7 weeks of
COVID-19 infection remain, unless the benefits of doing so exceed the risk of waiting.
Aiming at the above problems, we plan to carry out a multicenter prospective cohort study
to develop perioperative management according patients' different conditions.
Criteria for eligibility:
Study pop:
Colorectal cancer patients undergoing surgery with perioperative COVID-19 infection.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- undergoing colorectal cancer surgery
- infected with COVID-19 but nucleic acid test result is negative
- the patients compliance is good
- signed the consents voluntarily
Exclusion Criteria:
- undergoing emergency surgery(intestinal obstruction, intestinal perforation,
intestinal hemorrhage, et al.)
- The patients' situations which judged by situations is not suitable to participate
in the clinical trial
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Start date:
January 15, 2023
Completion date:
June 1, 2024
Lead sponsor:
Agency:
Changhai Hospital
Agency class:
Other
Source:
Changhai Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05682898
